안녕하십니까? 코아스템 입니다.
금일 오후 공시를 통해 전해 드린' 주주 총회 소집 공고'와 '주식 매수청구권 행사' 안내와 관련하여
내용을 확인하지 못하신 분들이 있을 수 있기에 본 내용을 홈페이지 공지사항를 통해
다시 한번 전해 드립니다.
또한 주식매수청구권 행사 안내 내용에는 주식매수 청구를 위한 양식을 다운 받을 수 있기에
이점 참고를 부탁드립니다.
Corestem is a biopharmaceutical company that researches and commercializes stem cell technology.
We are dedicated to developing and advancing new therapies that improve the quality of life of patients suffering from intractable and rare diseases.SEE MORE
Based on our experience in the development and commercialization of ALS stem cell therapies, we develop therapeutic agents for rare and intractable diseases.SEE MORE
We have been eagerly challenging our research and development to fulfill the unmet needs for patients who have waited for years for treatmentSEE MORE
Screening and identifying candidates for disease areas and therapeutic purposes
Collecting the important feasibility, iterative testing and drug safety data from in vitro and in vivo
Generating data on safety and efficacy in human
Permission through safety, efficacy, standards and test methods, drug manufacturing and quality control assessment
We have focused on R&D for stem cell therapies in rare and incurable disease, promoting scientific progress, and expanding our knowledge of disease for patients.SEE MORE
Creating maximized value through strategic R&D in intractable disease